Search

Displaying results 7641 - 7650 of 10000 in total
  1. Drug

    Lamifiban

    go.drugbank.com/drugs/DB20451
    Experimental

    Lamifiban is a small molecule drug. The usage of the INN stem '-fiban' in the name indicates that Lamifiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist). … Lamifiban has a monoisotopic molecular weight of 468.2 Da.

  2. Drug

    Lotrafiban

    go.drugbank.com/drugs/DB20872
    Experimental

    Lotrafiban is a small molecule drug. The usage of the INN stem '-fiban' in the name indicates that Lotrafiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist). … Lotrafiban has a monoisotopic molecular weight of 428.24 Da.

    Categories: Platelet Glycoprotein GPIIb-IIIa Complex, antagonists & inhibitors
  3. Drug

    Human Embryonic Stem Cell-derived M Cell

    go.drugbank.com/drugs/DB15734
    Investigational

    However, the difference comes with IMRCs displaying a higher quality of consistency, having stronger immunomodulatory and anti-fibrotic functions, and being stronger in potential treatment of lung injury … IMRCs are similar to MSCs in terms of their capacity for self-renewal and tri-lineage differentiation.

  4. Drug

    TY027

    go.drugbank.com/drugs/DB16500
    Investigational

  5. Drug

    Gabexate

    go.drugbank.com/drugs/DB12831
    Investigational

    Gabexate is a synthetic serine protease inhibitor which has been used as an anticoagulant. It also known to decrease production of inflammatory cytokines. … Gabexate has been investigated for use in cancer, ischemia-reperfusion injury, and pancreatitis.[A19218,A19219,A19220]

  6. Drug

    Relutrigine

    go.drugbank.com/drugs/DB21614
    Investigational

    Relutrigine is a small molecule drug. The usage of the INN stem '-trigine' in the name indicates that Relutrigine is a sodium channel blocker, signal transduction modulator. … Relutrigine is under investigation in clinical trial NCT07010471 (A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine).

  7. Drug

    Omberacetam

    go.drugbank.com/drugs/DB19956
    Experimental

    Omberacetam is a small molecule drug. The usage of the INN stem '-racetam' in the name indicates that Omberacetam is a piracetam type amide type nootrope agent. … Omberacetam has a monoisotopic molecular weight of 318.16 Da.

  8. Drug

    Vibozilimod

    go.drugbank.com/drugs/DB21505
    Experimental

    Vibozilimod is a small molecule drug. The usage of the INN stem '-imod' in the name indicates that Vibozilimod is a immunomodulator, both stimulant/suppressive and stimulant. … Vibozilimod has a monoisotopic molecular weight of 541.23 Da.

  9. Drug

    Zectivimod

    go.drugbank.com/drugs/DB21525
    Experimental

    Zectivimod is a small molecule drug. The usage of the INN stem '-imod' in the name indicates that Zectivimod is a immunomodulator, both stimulant/suppressive and stimulant. … Zectivimod has a monoisotopic molecular weight of 527.17 Da.

  10. Drug

    Vormatrigine

    go.drugbank.com/drugs/DB21731
    Investigational

    Vormatrigine is a small molecule drug. The usage of the INN stem '-trigine' in the name indicates that Vormatrigine is a sodium channel blocker, signal transduction modulator. … Vormatrigine has a monoisotopic molecular weight of 406.09 Da.